Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.
Subscribe

Sci. Signal., 2 November 2010
Vol. 3, Issue 146, p. re9
[DOI: 10.1126/scisignal.3146re9]

REVIEWS

Fibroblast Growth Factor Receptor Signaling Crosstalk in Skeletogenesis

Hichem Miraoui1,2 and Pierre J. Marie1*

1 Laboratory of Osteoblast Biology and Pathology, INSERM UMR606 and University Paris Diderot, Paris 75475, Cedex 10, France.
2 Harvard Reproductive Endocrine Sciences Center and Reproductive Endocrine Unit, Department of Internal Medicine, Massachusetts General Hospital, Boston, MA 02114, USA.

Gloss: Fibroblast growth factor receptor (FGFR) signaling controls a number of cellular processes. These functions are mediated by four FGFRs that are members of the receptor tyrosine kinase family. Studies of genetic models in mice and humans with FGFR mutations have provided evidence that inappropriate FGFR activity results in skeletal dysplasias. This Review, with three figures and 60 citations, describes the roles of FGFR signaling in determining skeletal cell fate and highlights how FGFR signaling cooperates with other signaling networks to control mesenchymal cell fate and differentiation. This crosstalk has important implications in potential treatment of skeletal disorders resulting from aberrant FGFR signaling.

* Corresponding author. INSERM U606, Hopital Lariboisiere, 2 rue Ambroise Pare, 75475 Paris cedex 10, France. E-mail: pierre.marie{at}inserm.fr

Citation: H. Miraoui, P. J. Marie, Fibroblast Growth Factor Receptor Signaling Crosstalk in Skeletogenesis. Sci. Signal. 3, re9 (2010).

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
The Genetics of Canine Skull Shape Variation.
J. J. Schoenebeck and E. A. Ostrander (2013)
Genetics 193, 317-325
   Abstract »    Full Text »    PDF »
Control of Mesenchymal Lineage Progression by MicroRNAs Targeting Skeletal Gene Regulators Trps1 and Runx2.
Y. Zhang, R.-l. Xie, J. Gordon, K. LeBlanc, J. L. Stein, J. B. Lian, A. J. van Wijnen, and G. S. Stein (2012)
J. Biol. Chem. 287, 21926-21935
   Abstract »    Full Text »    PDF »
The Casitas B Lineage Lymphoma (Cbl) Mutant G306E Enhances Osteogenic Differentiation in Human Mesenchymal Stromal Cells in Part by Decreased Cbl-mediated Platelet-derived Growth Factor Receptor {alpha} and Fibroblast Growth Factor Receptor 2 Ubiquitination.
N. Severe, H. Miraoui, and P. J. Marie (2011)
J. Biol. Chem. 286, 24443-24450
   Abstract »    Full Text »    PDF »
Inhibition of cellular senescence by developmentally regulated FGF receptors in mesenchymal stem cells.
D. L. Coutu, M. Francois, and J. Galipeau (2011)
Blood 117, 6801-6812
   Abstract »    Full Text »    PDF »
Conditional ablation of Pten in osteoprogenitors stimulates FGF signaling.
A. R. Guntur, M. I. Reinhold, J. Cuellar Jr, and M. C. Naski (2011)
Development 138, 1433-1444
   Abstract »    Full Text »    PDF »

To Advertise     Find Products

Science Signaling. ISSN 1937-9145 (online), 1945-0877 (print). Pre-2008: Science's STKE. ISSN 1525-8882